The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 20163116 |
116 |
The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist. |
Merck Frosst Centre For Therapeutic Research |
| 19036582 |
45 |
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain. |
Glaxosmithkline |
| 15686932 |
36 |
2,3-Diarylthiophenes as selective EP1 receptor antagonists. |
Merck Frosst Centre For Therapeutic Research |
| 28784294 |
37 |
Discovery of novel pyrazolo[1,5-a]pyridine-based EP |
Kyorin Pharmaceutical |
| 28483455 |
45 |
Identification of novel 1,2,3,6-tetrahydropyridyl-substituted benzo[d]thiazoles: Lead generation and optimization toward potent and orally active EP |
Kyorin Pharmaceutical |
| 28342692 |
32 |
Novel pyrazolo[1,5-a]pyridines as orally active EP |
Kyorin Pharmaceutical |
| 20518620 |
16 |
Synthesis of new 8(S)-HETE analogs and their biological evaluation as activators of the PPAR nuclear receptors. |
Universit?? De Rennes 1 |
Search and Browse
